Analytics
The funds will be used to develop a comprehensive AI imaging model powered by imaging data to improve diagnostic precisions and early detection of conditions.
The company showcased new informatics solutions at RSNA23 in Chicago, including a "helium-free" mobile MRI system and an AI-enabled advanced visualization workshop.
A study published in the New England Journal of Medicine says GPT-4 correctly diagnosed 52.7% of complex cases compared to only 36% of medical journal readers.
The company's product, Distill, uses machine learning algorithms and LLMs to perform administrative, clinical and research tasks that require chart review.
The company will use the funds to grow its drug-discovery pipeline and clinical AI stack.
The pharma giant's new health tech company will operate as a separate business and scale the company's already established digital technologies to enhance clinical trials.
The healthcare technology company will evaluate the impact of the City of San Antonio's Racial and Ethnic Approaches to Community Health (REACH) project.
Also, H2U has received strategic investment to take on the South Korean market.
Dr. Patrick Carroll, chief medical officer at Hims & Hers, describes the company's EMR and how its datasets power MedMatch, its new AI offering for mental health providers.
It has also obtained its third US FDA 510(k) clearance.